S2 Ep8: Outsmarting Breast Cancer Is Not That Simple

There were more than 2 million cases of breast cancer diagnosed in 2018 worldwide. While there are more than 3.8 million survivors in the U.S., which is more than any other group of cancer survivors, breast cancer is actually a very complex disease with many different subsets. Often times, it is informed decisions that allow patients to feel more confident about their treatment. Awareness is crucial to better outcomes, but the messaging should be broad and informative as a breast cancer diagnosis can be different for each patient. Joe talks with Michelle Bazer, oncology nurse, mother, and now breast cancer survivor, and Dr. Maura Dicker, VP of Late Phase Oncology Development at Lilly, about the factors that influence treatment decisions, the approaches our scientists are considering to “outsmart” breast cancer, and the significance of friendships during challenging times.

Om Podcasten

The Elixir Factor podcast brings researchers together with industry leaders, advocacy groups, patients, and their loved ones to discuss how Lilly tackles the world’s most significant health challenges. Tune in as we unpack complex science and innovative breakthroughs that can make life better for people around the world.